| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |